OKAIF (EvokAI Creative Labs) Common Stock : $18.76 Mil (As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is EvokAI Creative Labs Common Stock?

EvokAI Creative Labs's quarterly common stock stayed the same from Mar. 2024 ($18.76 Mil) to Jun. 2024 ($18.76 Mil) and stayed the same from Jun. 2024 ($18.76 Mil) to Sep. 2024 ($18.76 Mil).

EvokAI Creative Labs's annual common stock increased from Dec. 2021 ($1.59 Mil) to Dec. 2022 ($3.64 Mil) and increased from Dec. 2022 ($3.64 Mil) to Dec. 2023 ($18.76 Mil).

EvokAI Creative Labs Common Stock Historical Data

The historical data trend for EvokAI Creative Labs's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EvokAI Creative Labs Common Stock Chart

EvokAI Creative Labs Annual Data

Trend

Dec21

Dec22

Dec23

Common Stock

1.59

3.64

18.76

EvokAI Creative Labs Quarterly Data
	Dec21	Mar22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Common Stock	Get a 7-Day Free Trial						-	18.76	18.76	18.76	18.76

EvokAI Creative Labs Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

EvokAI Creative Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EvokAI Creative Labs Inc (OTCPK:OKAIF) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

OKAI:Canada

Address

609 Granville Street, Suite 1600, PO Box 10068, Pacific Centre, Vancouver, BC, CAN, V7Y 1C3

Website

https://www.evokailabs.com

EvokAI Creative Labs Inc is a medtech artificial-intelligence-powered company. It deploys machine learning models to search medical data and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide more accurate diagnoses. EvokAI tailors its AI algorithms across the whole healthcare system, from hospitals, private clinics, research institutions, pharmaceutical companies, and contract research organizations to medical professionals, patients, and healthy individuals aiming at preventing and early detecting any kind of disease and beyond, protecting the aging genome.